A new potential oncogenic mutation in the FERM domain of JAK2 in BCR-ABL1 negative and V617F negative chronic myeloproliferative neoplasms (CMPNs) revealed by a comprehensive screening of 17 tyrosine kinase coding genes [PDF]
, 2010 BCR/ABL1-negative chronic myeloproliferative neoplasms (CMPNs) are a heterogeneous group of clonal hematological malignancies. Over recent years, some genetic events in tyrosine kinase (TK) genes have been described as causal events of these diseases. To
Aranaz-Oroz, P. (Paula) +7 more
core
Histamine and Serotonin Levels in Bone Marrow Stem Cells Niche as Potential Biomarkers of Systemic Mastocytosis and Myeloproliferative Disorders. [PDF]
Stem Cell Rev Rep, 2023 Janus T +6 more
europepmc +1 more source
Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders. [PDF]
J Clin Med, 2021 Kuznetsova PI +7 more
europepmc +1 more source
Are Myeloproliferative Neoplasms‐Unclassifiable Really Unclassifiable?
eJHaem, Volume 7, Issue 2, April 2026.
Giovanni Barosi +2 more
wiley +1 more source
Myelodysplastic/myeloproliferative disorders
Haematologica, 2008 Luca Malcovati, Mario Cazzola
doaj +1 more source
Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria [PDF]
, 2017 Myeloproliferative neoplasms (MPN), Essential Thrombocythemia (ET), Polycythemia Vera (PV) and primary myelofibrosis (PMF), are clonal disorders of the hematopoietic stem cell.
Bertozzi, Irene
core +1 more source
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
New England Journal of Medicine, 2005 R. Kralovics +8 more
semanticscholar +1 more source
Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders. [PDF]
Cureus, 2021 Hamid MAB, Sehbai AS, Tariq S.
europepmc +1 more source
Neutralize the neutrophils! Neutrophil β1 /β2 integrin activation contributes to JAK2-V617F–driven thrombosis [PDF]
, 2018 Barbui +4 more
core +2 more sources